Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Verona Pharma PLC is a clinical-stage biopharmaceutical company. It is known for developing therapeutics for the treatment of respiratory diseases with unmet medical needs. Its product lines comprise anti-inflammatory agent and bronchodilators, which have markets in the United Kingdom, Germany, Romania, Bulgaria, and many others.
London, SE1 2RE, United Kingdom